Real-world findings show anatomical improvement and longer treatment intervals in eyes with nAMD, suggesting better management strategies.
In pretreated nAMD eyes with high treatment demand, switching to Afl 8 resulted in a significant anatomical improvement and longer treatment intervals in a majority of patients. These real-world results highlight the therapeutic potential of Afl 8, with no new or unexpected safety issues.
No takes yet. Share an insight, caveat, or question.
Kitay et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: